Remote Fetal Monitoring in High Risk Pregnancies
Antenatal nonstress tests (NSTs) are performed to assess fetal health and are used as a cost-effective test that can be widely administered. However, an NST is operator-dependent due to the nature of Doppler ultrasound and is primarily performed in a clinic and hospital setting. The ability to conduct a clinically valuable test at home would address access to care issues faced by numerous women in the United States and reduce the workload on healthcare clinicians facing a shortage of human resources. This pilot…
Conditions studied
High Risk Pregnancy, Remote Patient Monitoring, Diabetes, Hypertension
About this study
Antenatal nonstress tests (NSTs) are performed to assess fetal health and are used as a cost-effective test that can be widely administered. However, an NST is operator-dependent due to the nature of Doppler ultrasound and is primarily performed in a clinic and hospital setting. The ability to conduct a clinically valuable test at home would address access to care issues faced by numerous women in the United States and reduce the workload on healthcare clinicians facing a shortage of human resources. This pilot study aims to assess the feasibility and acceptability of home NST monitoring in order to determine whether femomTM could be utilized as an adjunct to routine prenatal care. Patients with high risk pregnancies who are recommended to undergo at least once weekly at 32 weeks testing by the obstetrician will be recruited for participation in this study. Participants will be asked to perform three 30 minute monitoring sessions weekly starting at 32 weeks for 6 weeks.
Interventions
- Device: Fetal ECG monitoring — Patients will wear a fetal ECG monitor which they will place on their abdomen
Primary outcomes
- Percent of sessions completed (6 weeks)
- Percentage of interpretable sessions (6 weeks)
Eligibility information
Study locations
- Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.